Nature Biomedical Engineering, Published online: 03 November 2026; doi:10.1038/s41551-026-01829-x Orally delivered magnetoelectric particles activate vagal afferent fibres in the gut−brain axis and influence neurodegeneration and neuroinflammation in mouse models of Parkinson’s disease.
Cam-Hoa Mac, et al. “Non-invasive oral magnetoelectric vagus nerve neuromodulation for Parkinson’s disease therapy.” Nature Biomedical Engineering, 2026. doi:10.1038/s41551-026-01829-x.
@article{Mac2026,
title = {Non-invasive oral magnetoelectric vagus nerve neuromodulation for Parkinson’s disease therapy},
author = {Mac, Cam-Hoa and Chang, Pei-Ju and Chu, Li-An and Lin, Ya-Hui and Wang, Jui-To and Lin, Cheng-Yueh and Yuan, Yu-Chen and Yao, Yuan and Nguyen, Dien Thi My and Chang, Yen and Chen, Yin-Hsu and Nguyen, Mai Thanh Thi and Lin, Yu-Jung and Sung, Hsing-Wen},
journal = {Nature Biomedical Engineering},
year = {2026},
doi = {10.1038/s41551-026-01829-x},
url = {https://www.nature.com/articles/s41551-026-01829-x}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...